What GLP-1s Really Cost in 2026
If the prices you've seen made your stomach drop, you're in the right place — and you have more options than you think. We did the legwork on every path, from the $1,349-a-month list price down to the new $50 Medicare Bridge, so you can see your real choices side by side. No hype, no scare tactics, just a clear map of what you'd actually pay.
Pricing reflects April 2026. Seed data — please verify before relying on it.
April 2026
Does paying more mean losing more?
Here's something reassuring: a bigger price tag doesn't buy bigger results. The priciest brand isn't the most effective, and some of the gentlest-on-your-wallet options hold their own. Use this to weigh cost against what really matters to you.
| Medication | Type | Monthly cost | Avg. weight loss |
|---|---|---|---|
| Foundayo (orforglipron) | Daily pill | $149/mo | 12.4% loss |
| Compounded semaglutide | Weekly injection | $175/mo | 15% loss |
| Wegovy subscription | Self-pay sub | $249/mo | 16% loss |
| Oral Wegovy | Daily pill | $299/mo | 13.6% loss |
| Ozempic | Weekly injection | $998/mo | 12% loss |
| Mounjaro | Weekly injection | $1,023/mo | 18% loss |
| Zepbound | Weekly injection | $1,060/mo | 21% loss |
| Wegovy (high dose) | Weekly injection | $1,349/mo | 20.7% loss |
| Medicare Bridge | From July 2026 | $50/mo | Covers Wegovy & Zepbound |
Price tiers
Find the budget bracket that fits you
It helps to picture your options in four simple bands — from the most affordable compounded route up to full retail. Find the one that matches your budget and start there.
Under $150/mo
- Brand pill with insurance — from $25/mo
- Medicare Bridge (from July 2026) — $50/mo
- Compounded telehealth — from $99/mo
- Self-pay brand pill — $149/mo
$150–$299/mo
- Compounded semaglutide — $175–$199/mo
- Compounded tirzepatide — $219–$280/mo
- Wegovy 12-month self-pay sub — $249/mo
- Brand pill + membership — $298/mo
$300–$500/mo
- Brand pen + membership — $348/mo
- Zepbound via LillyDirect — $349/mo
- Brand-name telehealth — $349–$399/mo
- Comprehensive programs — up to $499/mo
$900+/mo
- Rybelsus (oral diabetes) — $936/mo
- Ozempic (injection) — $998/mo
- Mounjaro (injection) — $1,023/mo
- Zepbound (obesity) — $1,060/mo
- Wegovy (obesity) — $1,349/mo
By medication
What each medication costs you
The list prices below are the full retail figure — what you'd pay at the counter with no insurance or discounts applied. They're the starting point, not the final word. Tap a drug for the complete breakdown and the cheaper ways in.
| Medication | Ingredient | List price | Guide |
|---|---|---|---|
| Ozempic | Semaglutide | $998/mo | Coming soon |
| Wegovy | Semaglutide | $1,349/mo | View guide |
| Mounjaro | Tirzepatide | $1,023/mo | View guide |
| Zepbound | Tirzepatide | $1,060/mo | Coming soon |
| Rybelsus | Semaglutide (oral) | $950/mo | Coming soon |
At a glance
The whole landscape, in one table
If you only have a minute, this is the picture: what real people pay, sorted by how they're covered. Find the row that sounds like your situation.
| Category | Monthly cost | Medications | Notes |
|---|---|---|---|
| Brand-name, paying cash | $900–$1,350 | Ozempic, Wegovy, Mounjaro, Zepbound | The full sticker price with no insurance. If you're commercially insured, a savings card can bring this down sharply. |
| Brand-name, with insurance | $25–$150 | Ozempic, Wegovy, Mounjaro, Zepbound | Your copay depends on your plan's tier. The encouraging news: more commercial plans now cover obesity, not just diabetes. |
| Medicare Bridge (from Jul 2026) | $50 | Wegovy, Zepbound | For Part D enrollees. It opens July 1, 2026 and runs as a 6-month program — a real first for Medicare. |
| Compounded semaglutide | $149–$499 | Compounded semaglutide / tirzepatide | Affordable, but not FDA-approved — and the semaglutide shortage has officially ended, which changes the rules. |
| Oral GLP-1 (brand pill) | $149–$1,100 | Oral Wegovy, Rybelsus, orforglipron (pending) | Oral Wegovy self-pay starts at $149/mo; orforglipron, a once-daily pill, is expected later in 2026. |
| Telehealth program fee | $99–$365 | Varies by provider | A monthly subscription that covers your visits and check-ins. Medication is often billed on top, so read the fine print. |
Guides
Go deeper on the topics that matter to you
Pick the question that's on your mind and we'll walk you through it, step by step.
Medicare Finally Covers GLP-1s — Here's How
From July 1, the Bridge program brings Wegovy and Zepbound down to $50 a month for many on Medicare. We explain who qualifies, how to enroll, and what takes over in 2027.
Read the guide Asked a lotPaying for Ozempic When You Have No Insurance
If you're staring at a four-figure price tag, take a breath. We walk through the savings programs, pharmacy-by-pharmacy prices, and gentler alternatives.
Read the guide CoverageWhere Your State Stands on GLP-1 Coverage
Medicaid coverage for weight loss looks completely different from one state line to the next. Find out exactly where yours lands and what the rules are.
Read the guideInsurance & coverage
Let's see what your coverage can do
Insurance is where most of the real savings hide. These two guides help you figure out what you already qualify for.
Your state's Medicaid rules, made simple
See whether your state covers GLP-1s through Medicaid, who qualifies, and exactly how the prior-authorization step works — in plain English.
Medicare's first-ever weight-loss coverage
Starting July 2026, Medicare covers Wegovy and Zepbound at $50 a month for the first time ever. Here's how to be ready for it.
By state
Start with where you live
Coverage really does come down to your zip code: 36 states cover GLP-1s for weight loss, while 15 don't yet. Find your state to see the rules that apply to you.
Good news for Medicare: coverage arrives July 2026
An estimated ~3.4 million people on Medicare will finally be able to get Wegovy and Zepbound through the Bridge program. We’ll help you make sure you don’t miss the window.
Save money
Four steps that genuinely lower the bill
You don't have to try everything at once. Work through these in order, and most people land somewhere far below the sticker price.
Start with the manufacturer savings cards
If you're commercially insured, Novo Nordisk and Eli Lilly run copay programs that can drop a brand-name medication to $25–$150 a month. It only takes a few minutes to sign up, so this is the first thing we'd check.
Don't take a first denial as final
A surprising number of prior-authorization denials get reversed on appeal. Ask your prescriber to document your BMI, any related conditions, and past attempts at diet and exercise — a thorough request often gets a yes the second time around.
Shop your pharmacies before you fill
Cash prices can vary by as much as 30% between two pharmacies on the same street. Compare with GoodRx, RxSaver, or Mark Cuban's Cost Plus Drugs first — it's a few minutes that can save real money.
If you're on Medicare, watch for the Bridge
If you're 65+ with Part D, mark your calendar: the Bridge program opens July 1, 2026 at $50 a month for Wegovy and Zepbound. For many people, that's the single biggest cost drop available.
Ready to find a provider?
We’ve independently reviewed our 6 featured GLP-1 programs on cost, safety, and whether they’re truly legitimate — so you can choose with confidence.
This is educational information from Barrett's Research, not medical advice — please talk things through with a qualified clinician. Figures are seed data; verify before relying on them.
Self-pay constant: Wegovy $199/mo · cheapest telehealth from $99/mo.
Still not sure what fits your budget?
That's completely normal — there's a lot to weigh. Take our 2-minute quiz and we'll match you on cost, insurance, and the medication you're leaning toward.